Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Cantor Fitzgerald
Farmers Insurance
Fish and Richardson
Express Scripts
Daiichi Sankyo
McKinsey
UBS
Accenture

Generated: May 27, 2018

DrugPatentWatch Database Preview

Iroko Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for IROKO PHARMS, and what generic alternatives to IROKO PHARMS drugs are available?

IROKO PHARMS has seven approved drugs.

There are thirteen US patents protecting IROKO PHARMS drugs.

There are eighty-nine patent family members on IROKO PHARMS drugs in twenty-four countries.

Summary for Iroko Pharms
International Patents:89
US Patents:13
Tradenames:5
Ingredients:3
NDAs:7

Drugs and US Patents for Iroko Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Iroko Pharms Llc ZORVOLEX diclofenac CAPSULE;ORAL 204592-001 Oct 18, 2013 RX Yes No 9,186,328 ➤ Try a Free Trial ➤ Try a Free Trial
Iroko Pharms Llc ZORVOLEX diclofenac CAPSULE;ORAL 204592-002 Oct 18, 2013 RX Yes Yes 9,017,721 ➤ Try a Free Trial Y ➤ Try a Free Trial
Iroko Pharms Llc ZORVOLEX diclofenac CAPSULE;ORAL 204592-001 Oct 18, 2013 RX Yes No 8,999,387 ➤ Try a Free Trial ➤ Try a Free Trial
Iroko Pharms Llc ZORVOLEX diclofenac CAPSULE;ORAL 204592-002 Oct 18, 2013 RX Yes Yes 9,186,328 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Iroko Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Iroko Pharms INDOCIN indomethacin SUPPOSITORY;RECTAL 017814-001 Aug 13, 1984 3,849,549 ➤ Try a Free Trial
Iroko Pharms INDOCIN SR indomethacin CAPSULE, EXTENDED RELEASE;ORAL 018185-001 Feb 23, 1982 4,173,626 ➤ Try a Free Trial
Iroko Pharms INDOCIN indomethacin SUPPOSITORY;RECTAL 017814-001 Aug 13, 1984 3,644,630 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for IROKO PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsules 18 mg and 35 mg ➤ Subscribe 2014-06-06
➤ Subscribe Capsules 5 mg and 10 mg ➤ Subscribe 2017-01-09

Non-Orange Book US Patents for Iroko Pharms

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,522,135 Formulation of indomethacin ➤ Try a Free Trial
8,735,450 Formulation of diclofenac ➤ Try a Free Trial
9,849,111 Formulation of indomethacin ➤ Try a Free Trial
9,095,496 Formulation of indomethacin ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Harvard Business School
Covington
Baxter
Merck
AstraZeneca
Cantor Fitzgerald
Accenture
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.